Abiopharma

Clinical trial NCT03505320 updates: 1. completion date: 2027-05-31 → 2027-11-30 2. primary completion date: 2026-07-31 → 2026-12-31

Clinical trial NCT03768570: primary completion date: 2026-06-30 → 2026-10-31.

Clinical trial NCT06538116 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-11 3. enrollment: 300 → 304 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04255849 updates: 1. completion date: 2026-07-01 → 2026-07-31 2. primary completion date: 2026-05-01 → 2026-07-31

Clinical trial NCT05966467 updates: 1. completion date: 2030-03-01 → 2029-09-27 2. primary completion date: 2030-03-01 → 2029-09-27

Clinical trial NCT06982846 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-04 3. primary completion date: 2026-05-01 → 2026-05-04 4. enrollment: 78 → 80 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06052631: start date: 2026-06-22 → 2026-06-23.

Clinical trial NCT04986579 updates: 1. completion date: 2028-06-01 → 2030-06-01 2. primary completion date: 2026-06-01 → 2028-06-01

Clinical trial NCT07473726 updates: 1. start date: 2026-05-17 → 2026-06-20 2. allocation: NON_RANDOMIZED → NA

Clinical trial NCT06104566: primary completion date: 2025-10-20 → 2026-12-31.